insights_auto
Hvorfor har MVIR gått ned? 2,69%?
Gå mer i dybdenchevron_right
MVIR:STO
Medivir AB
1,59 SEK
arrow_downward
−2,69%(−0,044) 1 D
1. okt., 17:29:42 GMT+2 · SEK
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for MVIR …
Åpne
1,62 SEK
Høy
1,64 SEK
Lav
1,57 SEK
Markedsverdi
993,73 mill.
Snittvolum
1,95 mill.
Volum
1,31 mill.
52 u høy
2,88 SEK
52 u lav
0,34 SEK
EPS
−0,37 SEK
Utestående aksjer
624,04 mill.
Antall ansatte
6
Åpne
1,62 SEK
Høy
1,64 SEK
Lav
1,57 SEK
Markedsverdi
993,73 mill.
Snittvolum
1,95 mill.
Volum
1,31 mill.
52 u høy
2,88 SEK
52 u lav
0,34 SEK
EPS
−0,37 SEK
Utestående aksjer
624,04 mill.
Antall ansatte
6
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 10 timer siden
VOO og SPY: Topp 3 katalysatorer for S&P 500-ETF-er i oktober
Vietnam.vn
·
for 21 timer siden
Hurtiglesning 1-10: Amerikanske obligasjonsrenter når det høyeste nivået siden 2002, og sender Dow Jones til sitt laveste punkt på nesten fire måneder.
Invezz
·
for 1 time siden
Dow stiger etter at amerikanske aksjer hentet seg da statsrenter nådde 24-års-topp
Fox Business
·
for 1 time siden
October could be a huge month for the stock market. Here's why.
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Om Medivir AB